Skip to content

Gilead Sciences GILD Operating Income

Operating Income at other companies

Incyte logo
IncyteINCY
$301.12M+46.8%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$69.79M-8.3%
Precigen logo
PrecigenPGEN
-$5.99M+73.5%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$34.64M-25.8%
Sutro Biopharma logo
Sutro BiopharmaSTRO
-$29.66M+56.7%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
-$81.04M+33.1%

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$153.76B+13.9%
Enterprise value$168.3B+10.7%
P/E16.7×-5.9×
P/S5.2×+0.5×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp
FCF margin34.4%+0.1pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gilead Sciences's operating income?
Gilead Sciences (GILD) reported operating income of $2.59B in Q1 2026.
How has Gilead Sciences's operating income changed year-over-year?
Gilead Sciences's operating income increased by 15.6% year-over-year, from $2.24B to $2.59B.
What is the long-term trend for Gilead Sciences's operating income?
Over 4 years (2021 to 2025), Gilead Sciences's operating income has grown at a 0.3% compound annual growth rate (CAGR), from $9.92B to $10.02B.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.